Piper Sandler analyst Matt O’Brien lowered the firm’s price target on CVRx (CVRX) to $12 from $20 and keeps an Overweight rating on the shares. The firm notes the company reported Q1 results that were in line with the pre-announcement. Management primarily attributed the miss to sales force realignment that was more substantial than initially anticipated. CVRx also lowered full year sales guidance by more than the miss in the quarter. Piper believes the new guidance is fairly set but there is no lay-up as it still anticipates some productivity improvement through year-end.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVRX:
- Positive Outlook for CVRx Amidst Challenges: Buy Rating Supported by Strategic Initiatives and Future Growth Potential
- CVRx Faces Downgrade: Sales Miss and Reorganization Challenges Lead to Sell Rating
- CVRx downgraded to Underweight from Neutral at JPMorgan
- CVRx, Inc. Reports Revenue Growth in Q1 2025
- CVRx sees FY25 revenue $55M-$58M, consensus $61.5M